Adjunctive Memantine Therapy for Cognitive Impairment in Chronic Schizophrenia: A Placebo-Controlled Pilot Study

OBJECTIVE: To investigate the effects of memantine, an N-methyl-d-aspartate (NMDA) receptor antagonist, on cognitive impairments in patients with chronic schizophrenia. METHODS: A 12-week, placebo-controlled trial was conducted to determine the effectiveness of memantine as an adjunctive treatment w...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jung Goo, Lee, Sae Woom, Lee, Bong Ju, Park, Sung Woo, Kim, Gyung Mee, Kim, Young Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neuropsychiatric Association 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372565/
https://www.ncbi.nlm.nih.gov/pubmed/22707968
http://dx.doi.org/10.4306/pi.2012.9.2.166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372565/
https://www.ncbi.nlm.nih.gov/pubmed/22707968
http://dx.doi.org/10.4306/pi.2012.9.2.166

Ejemplares similares